Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver Metastases

NCT06124729 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Bevacizumab Combined With PD-1 Monoclonal Antibody

Sponsor

The First Affiliated Hospital with Nanjing Medical University